Infectious Disease

We deliver high-quality, research-grade human biospecimens specifically designed to advance infectious disease research, public health initiatives, and next-generation diagnostic development. Our comprehensive sample portfolio includes whole blood, plasma, serum, saliva, nasopharyngeal and oropharyngeal swabs, sputum, stool, urine, PBMCs, and matched longitudinal matrices — all collected under strict ethical, biosafety, and regulatory frameworks.

Our collections support research across a wide spectrum of infectious conditions, including respiratory infections, viral outbreaks, bacterial and fungal pathogens, parasitic diseases, and emerging global health threats. This includes influenza, COVID-19, RSV, tuberculosis, pneumonia, HIV, hepatitis B and C, dengue, Zika, chikungunya, malaria, sepsis, antimicrobial-resistant infections, gastrointestinal pathogens, and zoonotic diseases.

Each biospecimen is processed using standardized protocols to preserve pathogen viability, nucleic acid integrity, and immunological markers — ensuring reproducibility across molecular, genomic, and immunological platforms. Rich clinical metadata enhances translational relevance and enables deeper insights into disease progression, host response, and therapeutic outcomes.

From early-stage assay development to large-scale surveillance studies, our infectious disease biospecimens accelerate innovation in diagnostics, therapeutics, vaccines, and public health preparedness.